Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Publication year range
1.
Musculoskelet Surg ; 105(1): 69-74, 2021 Apr.
Article in English | MEDLINE | ID: mdl-32036564

ABSTRACT

BACKGROUND: Various conservative treatments and surgical techniques have been reported in the literature as efficient and feasible measures to treat the cubital tunnel syndrome. However, there has been no consensus on the best management of the syndrome, and uniform standardised guidelines have not yet been accepted or introduced. With our study, we present our experience on the clinical efficacies and outcomes of the surgical techniques of neurolysis alone and neurolysis associated with ulnar nerve anterior transposition at the elbow joint in patients with neuropathic symptoms due to cubital tunnel syndrome. MATERIALS AND METHODS: A total of 107 patients with cubital tunnel syndrome were retrospectively enrolled, surgically treated and followed up in our study. The cohort was divided into two groups: 41 patients treated only with neurolysis of the ulnar nerve (Group 1), and 66 patients treated with neurolysis and anterior transposition (Group 2). Of the participants, 35 were women and 72 were men. The average age was 54 years. Significant comorbidities were preoperatively diagnosed in 26 patients. Conservative measures had been considered, followed by surgical management if appropriate. A pre-op electromyography was performed for all patients. All surgical procedures were performed by the same surgical team. A post-operative follow-up was carried out, and the findings were recorded. The "McGowan" and "Wilson and Krout" classifications and the DASH score were used. A satisfaction questionnaire was administered to all patients post-operatively at 2 weeks). RESULTS: Ulnar nerve neurolysis and anterior transposition surgery were all successfully performed. Overall complications were post-operative haematoma (8%) and wound problems (5%). In 6% there was recurrence of symptoms. In 11% there was no improvement of symptoms. Pre-op McGowan classifications for groups 1 and 2 were 0% and 0% (grade 0), 21% and 24% (grade 1), 46% and 44% (grade 2), and 33% and 34% (grade 3), respectively. The post-op McGowan classifications were 34% and 37% (grade 0), 39% and 40% (grade 1), 23% and 20% (grade 2), and 4% and 3% (grade 3), respectively. The post-op Wilson and Krout classifications were 45% and 46% (excellent), 26% and 28% (good), 19% and 15% (fair), and 10% and 11% (poor), respectively. The DASH score means for groups 1 and 2 were 14.8 and 15.2, respectively. A negative Froment's sign was present in 73.2% and 71.2%, respectively. In Group 1, the post-op satisfaction questionnaire scores were 0 for one patient, 1 for four patients, 2 for seven patients, 3 for ten patients, 4 for twelve patients and 5 for seven patients. In Group 2, the post-op satisfaction questionnaire scores were 0 for three patients, 1 for nine patients, 2 for twelve patients, 3 for fifteen patients, 4 for eighteen patients and 5 for nine patients. CONCLUSIONS: In our experience, the surgical technique to treat the cubital tunnel syndrome most efficiently and feasibly has not yet been established in terms of indications and outcomes. This is supported by the data present in the international literature. Good and similar results were obtained with neurolysis alone and neurolysis associated with anterior transposition of the ulnar nerve (in line with the international data). In conclusion, more high-quality studies of greater statistical power are needed to provide a consensus on the surgical indications and techniques to treat the cubital tunnel syndrome and to establish internationally standardised guidelines.


Subject(s)
Cubital Tunnel Syndrome , Cubital Tunnel Syndrome/surgery , Decompression, Surgical , Female , Follow-Up Studies , Humans , Male , Middle Aged , Retrospective Studies , Ulnar Nerve/surgery
2.
Planta Med ; 66(8): 768-9, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11199141

ABSTRACT

Six triterpenoids having a lupane and oleane skeleton were isolated from the leaves and young branches of Licania heteromorpha Bentham var. heteromorpha and were identified as: betulinic acid 1, alphitolic acid 2, 3 beta-O-trans-p-coumaroyl alphitolic acid 3, 3 beta-O-cis-p-coumaroyl alphitolic acid 4, 3 beta-O-trans-p-coumaroyl maslinic acid 5, 3 beta-O-cis-p-coumaroyl maslinic acid 6. The antimicrobial activity of these compounds was evaluated in vitro on clinically isolated microorganisms employing a microdilution method. Compounds 2, 3, 5, and 6 showed antimicrobial activity on Gram-positive bacteria and yeasts, whereas none of the six triterpenoids were active against Gram-negative organisms.


Subject(s)
Anti-Bacterial Agents/isolation & purification , Rosales/chemistry , Triterpenes/isolation & purification , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Magnetic Resonance Spectroscopy , Microbial Sensitivity Tests , Triterpenes/chemistry , Triterpenes/pharmacology
3.
Life Sci ; 65(14): 1455-61, 1999.
Article in English | MEDLINE | ID: mdl-10530797

ABSTRACT

Several antipsychotic drugs reverse the dopamine-induced inhibition of prolactin release by rat pituitary cell cultures. Paradoxically, at high doses and without dopamine, antipsychotic drugs can also inhibit prolactin secretion. The mechanism underlying this phenomenon is unclear. Some evidence suggests that these drugs have an agonistic action. We sought to verify whether clozapine and fluphenazine, at doses higher than those reversing dopamine-induced inhibition of prolactin secretion in vitro, show this paradoxical effect and eventually a partial agonistic action. Both antipsychotics inhibited prolactin secretion, clozapine at doses starting from 10(-6) M and fluphenazine from 10(-7) M. Haloperidol reversed clozapine-induced prolactin inhibition but left fluphenazine-induced inhibition unchanged. These in vitro findings suggest that clozapine has a partial agonistic action on dopaminergic receptors but fluphenazine does not.


Subject(s)
Antipsychotic Agents/pharmacology , Pituitary Gland/drug effects , Prolactin/metabolism , Animals , Cell Survival/drug effects , Cells, Cultured , Clozapine/pharmacology , Female , Fluphenazine/pharmacology , Pituitary Gland/cytology , Pituitary Gland/metabolism , Rats , Rats, Wistar , Secretory Rate/drug effects
4.
Jpn J Pharmacol ; 79(1): 89-99, 1999 Jan.
Article in English | MEDLINE | ID: mdl-10082322

ABSTRACT

Natural hydrophobic substances like bile salts (cholate, deoxycholate, chenodeoxycholate, lithocholate and their conjugates with glycine and taurine), fatty acids (caprylic, capric, lauric, myristic, palmitic, stearic, oleic, linoleic, arachidonic, eicosapentaenoic and docosahexaenoic acid) were much more active (EC50 approximately 10(-4)-10(-5) M) than selected amino acids (EC50 > 10(-2) M) and inorganic salts (EC50 approximately 10(-1) M) in inhibiting heat-induced denaturation of human serum albumin in vitro. Fish oil, rich in n-3-polyunsaturated acids such as eicosapentaenoic acid and docosahexaenoic acid, administered p.o. (1 ml/kg) in the rat, protected ex vivo (after 2 hr) serum against heat-induced denaturation more than bendazac, a known antidenaturant drug. Thus, we speculated that the antidenaturant activity of fish oil may be partly (in addition to the known effect on endogenous eicosanoid composition) responsible for its beneficial effects in rheumatoid arthritis and other rheumatic conditions. In this connection, it is of note that the in vitro antidenaturant activity of fish oil fatty acids was higher than that of known antidenaturant drugs such as bendazac and bindarit and nonsteroidal anti-inflammatory drugs like phenylbutazone and indomethacin which could exert beneficial effects in chronic inflammatory conditions by stabilizing endogenous proteins.


Subject(s)
Bile Acids and Salts/pharmacology , Fatty Acids/pharmacology , Protein Denaturation/drug effects , Administration, Oral , Amino Acids/pharmacology , Animals , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Blood Proteins/chemistry , Blood Proteins/drug effects , Cattle , Charcoal/pharmacology , Chemical Fractionation , Dialysis , Fetal Blood/chemistry , Fish Oils/pharmacology , Fish Oils/therapeutic use , Hot Temperature , Humans , Indazoles/pharmacology , Propionates/pharmacology , Rats , Rats, Wistar , Rheumatic Diseases/drug therapy , Salts/pharmacology , Serum Albumin/chemistry , Serum Albumin/drug effects , Sodium Chloride/pharmacology , Tromethamine/pharmacology
5.
Biol Reprod ; 59(4): 843-53, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9746734

ABSTRACT

The changes in glutathione-independent prostaglandin D2 synthetase (PGD-S) during maturation in the rat were determined in selected organs by an RIA using PGD-S purified from rat cerebrospinal fluid and a monospecific anti-rat PGD-S polyclonal antibody. In a survey of its tissue distribution in various organ extracts and biological fluids, it was found that the concentration of PGD-S was highest in the epididymis-about 6- and 80-fold greater than that in the brain and testis, respectively. During maturation, PGD-S concentration increased steadily in the testis and epididymis; this is in contrast to the pattern of changes in the brain and liver, which showed a general trend of decline. Reverse transcription-polymerase chain reaction and Southern blotting were used to demonstrate the presence of PGD-S mRNA transcript in the testis and in Sertoli and germ cells. In the epididymis, the steady-state PGD-S mRNA level was highest in the caput, followed by the cauda and corpus. Orchiectomy induced a drastic reduction of PGD-S concentration in all three epididymal compartments. Administration of dihydrotestosterone (DHT) failed to restore the reduced epididymal PGD-S level except in the caput epididymis, where 4 days after DHT treatment the level of PGD-S was restored to about 50% of the pre-orchiectomized level; this suggests that the epididymal PGD-S level is not entirely regulated by androgen and that another yet to be identified testicular factor(s) is likely to be involved in its regulation. Germ cell-conditioned medium was also shown to stimulate PGD-S expression in the Sertoli cell. These results illustrate that PGD-S is an important molecule in testicular and epididymal function and that it is likely involved in spermatogenesis and sperm maturation.


Subject(s)
Epididymis/enzymology , Epididymis/growth & development , Intramolecular Oxidoreductases/metabolism , Testis/enzymology , Testis/growth & development , Animals , Blotting, Northern , Blotting, Southern , Culture Media, Conditioned , Germ Cells/metabolism , Indicators and Reagents , Intramolecular Oxidoreductases/biosynthesis , Intramolecular Oxidoreductases/genetics , Lipocalins , Male , Orchiectomy , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Radioimmunoassay , Rats , Rats, Sprague-Dawley , Recombinant Proteins/biosynthesis , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Seminiferous Epithelium/enzymology , Seminiferous Epithelium/growth & development , Sertoli Cells/enzymology , Tissue Distribution
6.
Biol Reprod ; 59(1): 111-23, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9675001

ABSTRACT

Germ cells isolated from rat testes by trypsinization have been shown to yield unwanted artifacts in biological assays, since conditioned media derived from these germ cells (germ cell-conditioned media [GCCM]) can modulate Sertoli cell secretory function because of the presence of residual trypsin. To determine whether germ cells themselves can modulate Sertoli cell function, we isolated germ cells from tubules by a mechanical procedure and assessed the effect of these cells on Sertoli cell alpha2-macroglobulin (alpha2-MG) steady-state mRNA level. It was found that germ cells indeed could stimulate Sertoli cell alpha2-MG expression. This effect is probably mediated by a soluble factor(s) released from germ cells, since GCCM fractionated by HPLC contained multiple fractions that can stimulate Sertoli cell alpha2-MG expression dose-dependently. These results illustrate that germ cells play a role in regulating testicular alpha2-MG expression. Since Sertoli cells synthesize and secrete many of the serum proteins behind the blood-testis barrier that are also produced by hepatocytes, we sought to ascertain whether germ cells can affect hepatic alpha2-MG expression. When germ cells were cocultured with hepatocytes isolated from adult rats, the hepatocyte alpha2-MG steady-state mRNA level was shown to be stimulated by germ cells dose-dependently. Using different pools of fractions derived from GCCM after their fractionation by a preparative anion-exchange HPLC column, GCCM was found to contain a factor(s) that stimulated hepatocyte alpha2-MG expression dose-dependently. More importantly, the fractions that stimulated hepatocyte alpha2-MG expression had a retention time different from that of the factor(s) that affected Sertoli cell alpha2-MG expression. These data illustrate that germ cells secrete multiple biological factors capable of regulating alpha2-MG expression in the testis and the liver. In summary, this study reveals a possible physiological link between the testis and the liver in that germ cells may release a factor(s) capable of modulating alpha2-MG expression in both organs.


Subject(s)
Gene Expression Regulation , Liver/metabolism , Sertoli Cells/metabolism , Spermatozoa/physiology , alpha-Macroglobulins/genetics , Aging , Animals , Chemical Fractionation , Chromatography, High Pressure Liquid , Coculture Techniques , Culture Media, Conditioned , Dexamethasone/pharmacology , Interleukin-6/pharmacology , Liver Regeneration , Male , Proteins/isolation & purification , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , alpha-Macroglobulins/physiology
7.
J Pharm Pharmacol ; 49(3): 319-21, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9231354

ABSTRACT

The dopaminergic and antidopaminergic activity of drugs is frequently assayed in pituitary cell cultures. Here we describe a modified version of the assay based on the use of pituitary cells from prepubertal female rats. Under our experimental conditions (50,000 cells well-1, 2-day culture and 2-h drug-exposure) the assay yielded high selectivity and sensitivity for drug dopaminergic activity. D2 agonistic activity of bromocriptine could be observed at a concentration as low as 10(-15) M, the antagonistic activity of haloperidol at 10(-16) M. The assay also proved reproducible and simple enough for routine screening of dopaminergic activity. The assay enabled dopaminergic agonist and antagonist activity to be revealed at very low drug concentrations. The high sensitivity of the assay could be of advantage in studying dopaminergic activity in samples containing active substances present at low concentrations or for disclosing the activity of substances with low dopaminergic potency.


Subject(s)
Dopamine Agonists/pharmacology , Dopamine Antagonists/pharmacology , Dopamine/pharmacology , Pituitary Gland/drug effects , 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine/analogs & derivatives , 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine/pharmacology , Animals , Bromocriptine/pharmacology , Cell Count/drug effects , Cells, Cultured , Cyproheptadine/pharmacology , Drug Evaluation, Preclinical , Female , Haloperidol/pharmacology , Pituitary Gland/cytology , Pituitary Gland/metabolism , Prolactin/antagonists & inhibitors , Rats , Rats, Wistar , Spiperone/pharmacology
8.
Pharmacol Res ; 35(3): 173-5, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9229404

ABSTRACT

Although the atypical antipsychotic agent clozapine has little propensity to induce hyperprolactinemia in humans it increases serum prolactin levels in the rat. In this study, the effects of clozapine and of some typical antipsychotic drugs on basal and dopamine-mediated prolactin secretion from cultured rat pituitary cells were compared. Despite being less potent than the other antipsychotic agents tested, clozapine reverted the effect of dopamine on prolactin secretion in vitro. This finding suggests that clozapine interferes with dopamine receptors in the pituitary gland.


Subject(s)
Antipsychotic Agents/toxicity , Clozapine/toxicity , Dopamine/pharmacology , Pituitary Gland/drug effects , Pituitary Gland/metabolism , Prolactin/metabolism , Animals , Cells, Cultured , Chlorpromazine/toxicity , Fluphenazine/toxicity , Humans , Rats , Receptors, Dopamine/drug effects
9.
Clin Ter ; 137(4): 265-8, 1991 May 31.
Article in Italian | MEDLINE | ID: mdl-1831091

ABSTRACT

In this paper we have studied the rat under chronic treatment with Lobeline sulphate ip. For a three week period we have recorded, once a week, weight, rectal temperature, tail-flick, motor coordination and general activity in a one-arm radial maze and in a Boissier-Simon table. At the end of the third week surface (SEEG) and deep (DEEG) EEG were recorded both from treated and control animals. The findings are: 1) no changes was observed in weight, rectal temperature, tail-flick and motor coordination; 2) the treated rats showed an increased general activity both in a one-arm radial maze and in the Boissier-Simon table; 3) the EEG effects were analyzed and quantified, by means of Fast Fourier transform, as total power and as power in preselected bands of frequency. The lobeline sulphate seems to produce both in SEEG and hippocampus a shift toward low frequencies and in amygdala a drift toward high frequencies.


Subject(s)
Behavior, Animal/drug effects , Brain/drug effects , Plants, Medicinal , Animals , Behavior, Animal/physiology , Brain/physiology , Electroencephalography/drug effects , Lobeline/pharmacology , Male , Rats , Rats, Inbred Strains , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...